1-3 of 3
Jalila Chagraoui
Close
Sort by
Journal Articles

CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-X L inhibition by navitoclax and DT2216

Verena Gress, Mathieu Roussy, Luc Boulianne, Mélanie Bilodeau, Sophie Cardin, Nehme El-Hachem, Véronique Lisi, Banafsheh Khakipoor, Alexandre Rouette, Azer Farah, Louis Théret, Léo Aubert, Furat Fatima, Éric Audemard, Pierre Thibault, Éric Bonneil, Jalila Chagraoui, Louise Laramée, Patrick Gendron, Loubna Jouan, Safa Jammali, Bastien Paré, Shawn M. Simpson, Thai Hoa Tran, Michel Duval, Pierre Teira, Henrique Bittencourt, Raoul Santiago, Frédéric Barabé, Guy Sauvageau, Martin A. Smith, Josée Hébert, Philippe P. Roux, Tanja A. Gruber, Vincent-Philippe Lavallée, Brian T. Wilhelm, Sonia Cellot
Journal: Blood Advances
Blood Adv (2023) 8 (1): 112–129.
https://doi.org/10.1182/bloodadvances.2022008899
Published: 2023
Includes: Supplemental data
Journal Articles

HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition

Céline Moison, Jean-François Spinella, Jalila Chagraoui, Vincent-Philippe Lavallée, Bernhard Lehnertz, Clarisse Thiollier, Isabel Boivin, Nadine Mayotte, Tara MacRae, Anne Marinier, Josée Hébert, Guy Sauvageau
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4793–4806.
https://doi.org/10.1182/bloodadvances.2021005828
Published: 2022
Includes: Supplemental data
Journal Articles

CEACAM1 is a novel culture-compatible surface marker of expanded long-term reconstituting hematopoietic stem cells

Unain Ansari, Elisa Tomellini, Jalila Chagraoui, Bernhard Lehnertz, Nadine Mayotte, Marie-Eve Bordeleau, Philippe P. Roux, Guy Sauvageau
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3626–3631.
https://doi.org/10.1182/bloodadvances.2021006835
Published: 2022
Includes: Supplemental data